HHS Secretary Robert F. Kennedy Jr. is requiring all new vaccines to undergo placebo-controlled trials in a policy change described as a radical departure from past practices. This initiative aims to improve transparency and accountability in the testing and approval process of vaccines.
Key Points
New policy mandates placebo-controlled trials for all new vaccines
Criticism of CDC's surveillance system for vaccine complications
Call for greater transparency in vaccine testing and approval process
Pros
Improved safety testing for new vaccines
Increased transparency in vaccine testing and approval process
Cons
Concerns about exposing individuals to preventable illnesses through placebo trials